← Back to Search

Pharmacy Intervention Arm for Statin Therapy (CPATCH Trial)

N/A

Waitlist Available

Research Sponsored by University of Saskatchewan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

Despite proven benefits in reducing morbidity and mortality, many patients become nonadherent to statin therapy within the first year of starting. Due to their accessibility and frequent patient contact, pharmacists are well-positioned to improve medication adherence. The purpose of this study is to determine whether a simple intervention by community pharmacists can improve statin adherence in new statin users.

Eligible Conditions

Statin Therapy
Compliance

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Mean statin adherence among all eligible new users of statin medications with at least 6 months of follow-up from index prescription

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Pharmacy Intervention ArmExperimental Treatment1 Intervention

All patients receiving statins from pharmacies allocated to the pharmacist intervention arm of the study

Group II: Usual CareActive Control1 Intervention

Pharmacies not allocated to the intervention arm will serve as the control. They received no training on the CPATCH intervention and provide usual care to patients at their pharmacy.

Do I qualify?Apply below to find out